Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Janet Allenby

Dermatology Delray Beach, FL Doctor of Osteopathy

NPI 1437242054 CMS profile 20269

6290 Linton Blvd., Suite 204, Delray Beach, FL 33484

Open in the dashboard

General payments

$459,147

588 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Janet Allenby of Delray Beach, FL is reported in the CMS Open Payments database as having received $459,147 across 588 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $14,809 81
2024 General $37,107 66
2023 General $73,362 75
2022 General $178,189 90
2021 General $119,648 99
2020 General $21,689 67
2019 General $14,344 110

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Janet Allenby
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Janet Allenby were reported at $14,809. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Janet Allenby Dermatology median Middle half National median
2019 $14,344 $454 $129–$1,240 $163
2020 $21,689 $235 $81–$756 $114
2021 $119,648 $377 $108–$1,108 $132
2022 $178,189 $514 $143–$1,391 $149
2023 $73,362 $607 $159–$1,674 $160
2024 $37,107 $751 $204–$1,903 $164
2025 $14,809 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $282,417 206 payments
  2. AbbVie, Inc. $114,434 134 payments
  3. Galderma Laboratories, L.P. $53,967 165 payments
  4. Merz North America, Inc. $7,679 60 payments
  5. Musculoskeletal Transplant Foundation Inc. $284 6 payments
  6. Revance Therapeutics, Inc. $270 6 payments
  7. Pierre Fabre Pharmaceuticals, Inc. $60 9 payments
  8. Sientra, Inc. $37 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $260,661 30 payments
  2. Consulting Fee $173,888 44 payments
  3. Food and Beverage $16,166 481 payments
  4. Travel and Lodging $8,417 31 payments
  5. Education $15 2 payments
Products named General payments · program years 2019–2025
  1. BOTOX COSMETIC $12,929 39 payments
  2. BOTOX $3,936 19 payments
  3. Xeomin Dermatology $388 7 payments
  4. DAXXIFY $270 6 payments
  5. ASCLERA $180 3 payments
  6. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $37 2 payments
  7. HEMANGEOL $29 4 payments
  8. Xeomin musculoskeletal $26 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

588 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record